Thermo Fisher and SHL Medical collaborate to deliver fully integrated drug-device solutions

2026-04-12 04:15:23

Abstract generation in progress

Thermo Fisher Scientific has announced a strategic collaboration with SHL Medical and an expansion at its Ridgefield, NJ site to offer fully integrated drug-device solutions in the US. This initiative combines sterile manufacturing, device assembly, and commercial packaging, addressing the growing demand for patient-centric, self-administered injectable therapies. The partnership integrates SHL Medical’s Molly® autoinjector platform with Thermo Fisher’s capabilities, aiming to simplify development and commercialization for pharmaceutical and biotechnology clients.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes